Carregant...
A Holy Grail of asthma management: toward understanding how long-acting β(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
There is unequivocal evidence that the combination of an inhaled corticosteroid (ICS)—i.e. glucocorticoid—and an inhaled long-acting β(2)-adrenoceptor agonist (LABA) is superior to each component administered as a monotherapy alone in the clinical management of asthma. Moreover, Calverley and collea...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2275445/ https://ncbi.nlm.nih.gov/pubmed/18071293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707627 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|